To update current guidelines, with the new findings from the TRACT trial, a consensus severe anaemia management algorithm was developed with the aim of improving evidence-based clinical practice and averting the unnecessary use of transfusion in children with uncomplicated severe anaemia.32 However, two vital components of the transfusion management algorithm included both clinical and Hb monitoring. The gene discussed is GSTM1; the disease is anemia.